JCOG2002: A randomized phase III study of thoracic radiotherapy for extensive stage small cell lung cancer. Sacituzumab tirumotecan (SKB264/MK-2870) in combination with KL-A167 (anti-PD-L1) as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results